View Cart  

Court Orders FDA to Approve Watson’s Actos ANDA, Award Exclusivity

A A
A district court has ordered the FDA to immediately approve Watson’s ANDA for a generic of Takeda’s billion-dollar diabetes treatment Actos.

To View This Article:

Login

Subscribe To Generic Line

Buy This Article Now

Add this article to your cart for $40.00